Form 8-K - Current report:
SEC Accession No. 0000059478-24-000213
Filing Date
2024-09-09
Accepted
2024-09-09 07:03:46
Documents
17
Period of Report
2024-09-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lly-20240905.htm   iXBRL 8-K 51971
2 EX-99.1 ecannouncement_pressreleas.htm EX-99.1 11219
7 image_0a.jpg GRAPHIC 13776
8 image_1a.jpg GRAPHIC 12759
  Complete submission text file 0000059478-24-000213.txt   326129

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20240905.xsd EX-101.SCH 4616
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20240905_def.xml EX-101.DEF 19611
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20240905_lab.xml EX-101.LAB 37978
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20240905_pre.xml EX-101.PRE 20830
19 EXTRACTED XBRL INSTANCE DOCUMENT lly-20240905_htm.xml XML 10543
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 241285773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)